Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.76 CAD Market Closed
Market Cap: 1.1B CAD

Operating Margin
Cronos Group Inc

-39.5%
Current
-105%
Average
6.5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-39.5%
=
Operating Profit
-49.2m
/
Revenue
124.6m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CA
Cronos Group Inc
TSX:CRON
1.1B CAD
-39%
US
Eli Lilly and Co
NYSE:LLY
739.9B USD
40%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
375.3B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK
45%
CH
Roche Holding AG
SIX:ROG
206.8B CHF
33%
CH
Novartis AG
SIX:NOVN
192.2B CHF
33%
UK
AstraZeneca PLC
LSE:AZN
160.3B GBP
24%
US
Merck & Co Inc
NYSE:MRK
203.6B USD
34%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
11%
US
Pfizer Inc
NYSE:PFE
144.3B USD
27%

Cronos Group Inc
Glance View

Market Cap
1.1B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.65 CAD
Overvaluation 40%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-39.5%
=
Operating Profit
-49.2m
/
Revenue
124.6m
What is the Operating Margin of Cronos Group Inc?

Based on Cronos Group Inc's most recent financial statements, the company has Operating Margin of -39.5%.

Back to Top